Literature DB >> 23860633

[Administrative prevalence, treatment and costs of somatoform pain disorder. Analysis of data of the BARMER GEK for the years 2008-2010].

W Häuser1, U Marschall, H L'hoest, K Komossa, P Henningsen.   

Abstract

INTRODUCTION: Data on administrative prevalence, types of treatment and disease costs of patients diagnosed with somatoform pain disorder (according to ICD 10) in Germany were not previously available.
MATERIALS AND METHODS: We analysed health insurance data from 2008-2010 of 8.5 million people of the German statutory health insurance company BARMER GEK on administrative prevalence of insurants with at least one billing code F 45.4x in 2009 and at least one second billing code F 45.4x in the time period 2008-2010 stratified by age and gender, different professions being involved in treatment, diagnostics and treatment methods applied. The types and costs of out-patient treatment and of in-patient treatment in case of any discharge with diagnosis of F45.4 were analysed.
RESULTS: The administrative prevalence doubled from 2008 to 2010 after the separation of the previous code F45.4 into F45.40 and F45.41. In 2009, 0.5 % of the insurants were diagnosed with F 45.4, whereby F 45.4 was diagnosed 2.3-fold more often in women than in men. Family practitioners (41 %) and anaesthesiologists (28 %) were the leading specialties in the care of chronic patients. In 2009, 54 % of patients underwent x-ray examination, 25 % magnetic resonance imaging and 11 % computed tomography. In all, 66 % of the chronic patients received basic psychosomatic care, 38 % were prescribed opioids, 12 % underwent spinal nerve anaesthesia and 14 % received psychotherapy. In 2009, the average direct and indirect treatment costs per patient with somatoform pain disorder were 5500 <euro>.
CONCLUSION: Insurants diagnosed with somatoform pain disorder were probably overtreated with radiology and invasive procedures and with opioids.

Entities:  

Mesh:

Year:  2013        PMID: 23860633     DOI: 10.1007/s00482-013-1340-z

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  19 in total

1.  Psychogenic pain and pain-prone patient.

Authors:  G L ENGEL
Journal:  Am J Med       Date:  1959-06       Impact factor: 4.965

2.  [Treatment and healthcare costs of fibromyalgia syndrome in Germany: analysis of the data of the Barmer health insurance (BEK) from 2008-2009].

Authors:  U Marschall; B Arnold; W Häuser
Journal:  Schmerz       Date:  2011-08       Impact factor: 1.107

3.  [Pain-specific diagnosis patterns in claims data - Identification by means of classification and regression trees (CART)].

Authors:  G Schiffhorst; A Freytag; A Höer; B Häussler; H Gothe
Journal:  Gesundheitswesen       Date:  2010-05-17

Review 4.  [Psychotherapy for patients with fibromyalgia syndrome. Systematic review, meta-analysis and guideline].

Authors:  V Köllner; W Häuser; K Klimczyk; H Kühn-Becker; M Settan; M Weigl; K Bernardy
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

Review 5.  [Epidemiology of chronic non-malignant pain in Germany].

Authors:  R Wolff; C Clar; C Lerch; J Kleijnen
Journal:  Schmerz       Date:  2011-02       Impact factor: 1.107

6.  Somatoform pain disorder in the general population.

Authors:  Hans Joergen Grabe; Christian Meyer; Ulfert Hapke; Hans-Juergen Rumpf; Harald Juergen Freyberger; Horst Dilling; Ulrich John
Journal:  Psychother Psychosom       Date:  2003 Mar-Apr       Impact factor: 17.659

7.  Redefining (somatoform) pain disorder in ICD-10: a compromise of different interest groups in Germany.

Authors:  Winfried Rief; Michael Zenz; Ullrich Schweiger; Heinz Rüddel; Peter Henningsen; Paul Nilges
Journal:  Curr Opin Psychiatry       Date:  2008-03       Impact factor: 4.741

8.  [S3 guideline LONTS. Long-term administration of opioids for non-tumor pain].

Authors:  H Reinecke; H Sorgatz
Journal:  Schmerz       Date:  2009-10       Impact factor: 1.107

9.  [Intensity of limb pain and fatigue in fibromyalgia syndrome, depressive disorders and chronic back pain. A criterion for differentiation].

Authors:  W Häuser; N Grulke; D Michalski; A Hoffmann; I Akritidou; S Klauenberg; C Maier; A Hinz
Journal:  Schmerz       Date:  2009-06       Impact factor: 1.107

Review 10.  Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews.

Authors:  Kurt Kroenke; Erin E Krebs; Matthew J Bair
Journal:  Gen Hosp Psychiatry       Date:  2009-03-04       Impact factor: 3.238

View more
  11 in total

Review 1.  [Stress-induced hyperalgesia (SIH) as a consequence of emotional deprivation and psychosocial traumatization in childhood : Implications for the treatment of chronic pain].

Authors:  U T Egle; N Egloff; R von Känel
Journal:  Schmerz       Date:  2016-12       Impact factor: 1.107

2.  [Chronic pain disorder with somatic and psychological factors : A diagnosis initiated by professional politics awaits its scientific validation].

Authors:  W Häuser
Journal:  Schmerz       Date:  2018-06       Impact factor: 1.107

3.  [Diagnosis F45 is scientifically reliable].

Authors:  P Nilges; W Rief; U Kaiser; J Lutz; M Pfingsten; B Arnold
Journal:  Schmerz       Date:  2018-06       Impact factor: 1.107

4.  The Prevalence, Comorbidity, Management and Costs of Irritable Bowel Syndrome.

Authors:  Winfried Häuser; Ursula Marschall; Peter Layer; Thomas Grobe
Journal:  Dtsch Arztebl Int       Date:  2019-07-08       Impact factor: 5.594

Review 5.  [Methodology of the development of the updated LONTS guidelines for long-term administration of opioids in noncancer pain].

Authors:  W Häuser; P Klose; P Welsch; F Petzke; M Nothacker; I Kopp
Journal:  Schmerz       Date:  2015-02       Impact factor: 1.107

Review 6.  [Recommendations of the updated LONTS guidelines. Long-term opioid therapy for chronic noncancer pain].

Authors:  W Häuser; F Bock; P Engeser; G Hege-Scheuing; M Hüppe; G Lindena; C Maier; H Norda; L Radbruch; R Sabatowski; M Schäfer; M Schiltenwolf; M Schuler; H Sorgatz; T Tölle; A Willweber-Strumpf; F Petzke
Journal:  Schmerz       Date:  2015-02       Impact factor: 1.107

7.  Older patients with persistent postural-perceptual dizziness exhibit fewer emotional disorders and lower vertigo scores.

Authors:  Li Zhang; Weiwei Jiang; Lu Tang; Hongxing Liu; Feng Li
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

8.  [Healthcare services research on pain in Germany. A survey].

Authors:  W Häuser; E Neugebauer; F Petzke
Journal:  Schmerz       Date:  2015-10       Impact factor: 1.107

9.  [Treatment of myofascial lumbar dorsal pain. Effective clinical diagnostics and therapy].

Authors:  R Levene; O Günther; H-J Rothkötter; N Bitterlich; J Buchmann
Journal:  Schmerz       Date:  2014-12       Impact factor: 1.107

10.  Patients with somatoform disorders: More frequent attendance and higher utilization in primary Out-of-Hours care?

Authors:  Ruediger Leutgeb; Sarah Berger; Joachim Szecsenyi; Gunter Laux
Journal:  PLoS One       Date:  2018-08-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.